FDA Approved in 2019: Pitolisant (Wakix) for treatment of narcolepsy

Of 35 new drug approvals in 2019, pitolisant was among them. This drug was designed to treat excessive daytime sleepiness (EDS) in adults with narcolepsy. The mechanism by which pitolisant elicits its effects occurs via H3 receptors in the brain. Histamine is an important neurotransmitter with respect to the sleep-wake cycle. Pitolisant is an antagonist/inverse […]

Read More…

Privacy Statement